Tissue and Organ ProcurementTissue DonorsOrgan TransplantationBrain DeathKidney TransplantationWaiting ListsPresumed ConsentLiver TransplantationCadaverLiving DonorsTissue and Organ HarvestingDonor SelectionGraft SurvivalDirected Tissue DonationTransplantationTransplantsTissue BanksLiver FailureDeathUnited StatesHeart TransplantationGraft RejectionOrgan PreservationRetrospective StudiesUnited States Health Resources and Services AdministrationEnd Stage Liver DiseasePrinciple-Based EthicsTreatment OutcomeTransplantation, HomologousHospitals, SpecialFacility Regulation and ControlHealth Care RationingTime FactorsLung TransplantationPatient SelectionImmunosuppressive AgentsRegistriesValue-Based PurchasingInformed ConsentPancreas TransplantationLiver DiseasesMedicareKidney Failure, ChronicHistocompatibility TestingEthics, MedicalPostoperative ComplicationsRisk FactorsBone Marrow TransplantationRisk AssessmentFamilyHematopoietic Stem Cell TransplantationSurvival RateFollow-Up StudiesDrugs, EssentialProportional Hazards ModelsSurvival AnalysisProspective StudiesOrgan Preservation SolutionsPosthumous ConceptionGerminal CenterCytomegalovirus InfectionsIncidenceFacial TransplantationMultivariate AnalysisMultiple Organ FailureCohort StudiesPostoperative CareTransplantation, AutologousChild Day Care CentersPurchasing, HospitalGraft vs Host DiseaseOrgan SizeDissectionHealth Services AccessibilityTissue PreservationRecurrenceOrgan SpecificityOrgan of CortiPrognosisCold IschemiaSeverity of Illness IndexOutcome Assessment (Health Care)KidneyTrauma CentersTertiary Care CentersCyclosporineCommunity Health CentersTacrolimusResource AllocationRaffinoseCommission on Professional and Hospital ActivitiesImmunosuppressionIslets of Langerhans TransplantationNegotiatingFinancial Management